Laboratory tests as short-term correlates of stroke

BMC Neurology - Tập 16 - Trang 1-13 - 2016
Trevor Sughrue1,2, Michael A. Swiernik1, Yang Huang1, James P. Brody2,3
1Kaiser Permanente Southern California, San Diego, USA
2Department of Biomedical Engineering, University of California, Irvine, Irvine, USA
3Department of Biomedical Engineering, Henry Samueli School of Engineering, University of California, Irvine, USA

Tóm tắt

The widespread adoption of electronic health records provides new opportunities to better predict which patients are likely to suffer a stroke. Using electronic health records, we assessed the correlation of different laboratory tests to future occurrences of a stroke. We examined the electronic health records of 2.4 million people over a two year time span. These records contained 26,964 diagnoses of stroke. Using Cox regression analysis, we measured whether any one of 1796 different laboratory tests were effectively correlated with a future diagnosis of stroke. We identified 38 different laboratory tests that had significant short-term (two year) prognostic value for a future diagnosis of stroke. For each of the 38 laboratory tests we also compiled the Kaplan-Meier survival curve, and relative risk ratio that the test confers. Several dozen laboratory tests are effective short-term correlates of stroke.

Tài liệu tham khảo

Wolf PA, D’Agostino RB, Belanger AJ, Kannel WB. Probability of stroke: a risk profile from the Framingham Study. Stroke. 1991;22:312–8.

D’Agostino RB, Wolf PA, Belanger AJ, Kannel WB. Stroke risk profile: adjustment for antihypertensive medication. The Framingham Study. Stroke. 1994;25:40–3.

Lumley T, Kronmal RA, Cushman M, Manolio TA, Goldstein S. A stroke prediction score in the elderly: validation and Web-based application. J Clin Epidemiol. 2002;55:129–36.

Tanne D, Yaari S, Goldbourt U. Risk Profile and Prediction of Long-Term Ischemic Stroke Mortality A 21-Year Follow-up in the Israeli Ischemic Heart Disease (IIHD) Project. Circulation. 1998;98:1365–71.

Marler JR, Tilley BC, Lu M, Brott TG, Lyden PC, Grotta JC, et al. Early stroke treatment associated with better outcome: the NINDS rt-PA stroke study. Neurology. 2000.

Sittig DF, Singh H. Electronic health records and national patient-safety goals. N Engl J Med. 2012;367:1854–60.

Meeks DW, Smith MW, Taylor L, Sittig DF, Scott JM, Singh H. An analysis of electronic health record-related patient safety concerns. J Am Med Inform Assoc. 2014;21:1053–9.

Manolio TA, Kronmal RA, Burke GL, O’Leary DH, Price TR. Short-term predictors of incident stroke in older adults. The Cardiovascular Health Study. Stroke. 1996;27:1479–86.

Fried LP, Borhani NO, Enright P, Furberg CD, Gardin JM, Kronmal RA, et al. The Cardiovascular Health Study: design and rationale. Ann Epidemiol. 1991;1:263–76.

Schneeweiss S. Learning from big health care data. N Engl J Med. 2014;370:2161–3.

Tatonetti NP, Ye PP, Daneshjou R, Altman RB. Data-driven prediction of drug effects and interactions. Sci Transl Med. 2012;4:125ra31.

Tatonetti NP, Denny JC, Murphy SN, Fernald GH, Krishnan G, Castro V, et al. Detecting drug interactions from adverse-event reports: interaction between paroxetine and pravastatin increases blood glucose levels. Clin Pharmacol Ther. 2011;90:133–42.

Kho AN, Hayes MG, Rasmussen-Torvik L, Pacheco JA, Thompson WK, Armstrong LL, et al. Use of diverse electronic medical record systems to identify genetic risk for type 2 diabetes within a genome-wide association study. J Am Med Inform Assoc. 2012;19:212–8.

Brownstein JS, Murphy SN, Goldfine AB, Grant RW, Sordo M, Gainer V, et al. Rapid identification of myocardial infarction risk associated with diabetes medications using electronic medical records. Diabetes Care. 2010;33:526–31.

Reis BY, Kohane IS, Mandl KD. Longitudinal histories as predictors of future diagnoses of domestic abuse: modelling study. BMJ. 2009;339:b3677.

Chen C, Garrido T, Chock D, Okawa G, Liang L. The Kaiser Permanente Electronic Health Record: transforming and streamlining modalities of care. Health Aff (Millwood). 2009;28:323–33.

Kaiser Permanente. Fast Facts about Kaiser Permanente [Internet]. 2014 [cited 2015 Jun 17]. Available from: http://share.kaiserpermanente.org/article/fast-facts-about-kaiser-permanente/

McDonald CJ. LOINC, a Universal Standard for Identifying Laboratory Observations: A 5-Year Update. Clin Chem. 2003;49:624–33.

Huff SM, Rocha RA, McDonald CJ, De Moor GJ, Fiers T, Bidgood WD, et al. Development of the Logical Observation Identifier Names and Codes (LOINC) vocabulary. J Am Med Inform Assoc. 1998;5:276–92.

COX DR. Partial likelihood. Biometrika. 1975;62:269–76.

Lin DY. Cox regression analysis of multivariate failure time data: The marginal approach. Stat Med. 1994;13:2233–47.

An R Companion to Applied Regression [Paperback]. NY USA: SAGE Publications, Inc; Second Edition edition; 2010.

R Development Core Team R. R: A Language and Environment for Statistical Computing. R Found. Stat. Comput. 2011;409.

Khosla A, Cao Y, Lin CC-Y, Chiu H-K, Hu J, Lee H. An integrated machine learning approach to stroke prediction. Proc 16th ACM SIGKDD Int Conf Knowl Discov data Min - KDD’10. New York, New York, USA: ACM Press; 2010. p. 183.

Khella S, Bleicher MB. Stroke and its prevention in chronic kidney disease. Clin J Am Soc Nephrol. 2007;2:1343–51.

Wolf P, Abbott R, Kannel W. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 1991;22:983–8.

Cockcroft DW, Gault MH. Prediction of Creatinine Clearance from Serum Creatinine. Nephron. 1976;16:31–41. Karger Publishers.

Levey AS. A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation. Ann Intern Med. 1999;130:461. American College of Physicians.

Wannamethee SG, Shaper AG, Perry IJ. Serum Creatinine Concentration and Risk of Cardiovascular Disease : A Possible Marker for Increased Risk of Stroke. Stroke. 1997;28:557–63.

Shulman NB, Ford CE, Hall WD, Blaufox MD, Simon D, Langford HG, et al. Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group. Hypertension. 1989;13:I80–93.

Troughton RW, Frampton CM, Yandle TG, Espiner EA, Nicholls MG, Richards AM. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations. Lancet. 2000.

Maisel A. B-type natriuretic peptide levels: diagnostic and prognostic in congestive heart failure: what’s next? Circulation. 2002;105:2328–31.

Wallen T, Landahl S, Hedner T, Nakao K, Saito Y. Brain natriuretic peptide predicts mortality in the elderly. Heart. 1997;77:264–7.

Struthers AD. Introducing a new role for BNP: as a general indicator of cardiac structural disease rather than a specific indicator of systolic dysfunction only. Heart. 2002;87:97–8.

Mortel KF, Meyer JS, Sims PA, McClintic K. Diabetes mellitus as a risk factor for stroke. South Med J. 1990;83:904–11.

Krishna PR, Naresh S, Krishna GSR, Lakshmi AY, Vengamma B, Kumar VS. Stroke in chronic kidney disease. Indian J Nephrol. 2009;19:5–7.

Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med. 1977;62:707–14.

Iso H, Jacobs DR, Wentworth D, Neaton JD, Cohen JD. Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial. N Engl J Med. 1989;320:904–10.

Bowman TS, Sesso HD, Ma J, Kurth T, Kase CS, Stampfer MJ, et al. Cholesterol and the risk of ischemic stroke. Stroke. 2003;34:2930–4.

Wang W, Zhang B. Statins for the prevention of stroke: a meta-analysis of randomized controlled trials. PLoS One. 2014;9, e92388.

Shovlin CL, Chamali B, Santhirapala V, Livesey JA, Angus G, Manning R, et al. Ischaemic strokes in patients with pulmonary arteriovenous malformations and hereditary hemorrhagic telangiectasia: associations with iron deficiency and platelets. PLoS One. 2014;9:e88812. Public Library of Science.

Weng L-C, Yeh W-T, Bai C-H, Chen H-J, Chuang S-Y, Chang H-Y, et al. Is ischemic stroke risk related to folate status or other nutrients correlated with folate intake? Stroke. 2008;39:3152–8. Lippincott Williams & Wilkins.

Gillum RF, Sempos CT, Makuc DM, Looker AC, Chien C-Y, Ingram DD. Serum Transferrin Saturation, Stroke Incidence, and Mortality in Women and Men: The NHANES I Epidemiologic Followup Study. Am J Epidemiol. 1996;144:59–68.

Høstmark AT, Tomten SE. Serum albumin and self-reported prevalence of stroke: a population-based, cross-sectional study. Eur J Cardiovasc Prev Rehabil. 2006;13:87–90.

Xu W-H, Dong C, Rundek T, Elkind MSV, Sacco RL. Serum albumin levels are associated with cardioembolic and cryptogenic ischemic strokes: Northern Manhattan Study. Stroke. 2014;45:973–8.

Gillum RF, Ingram DD, Makuc DM. Relation between serum albumin concentration and stroke incidence and death: the NHANES I Epidemiologic Follow-up Study. Am J Epidemiol. 1994;140:876–88.

Hripcsak G, Albers DJ, Perotte A. Parameterizing time in electronic health record studies. J Am Med Inform Assoc. 2015.

Kaiser Permanente. Measuring Care Quality: For Clinical Effectiveness of Care Measures of Performance. 2014.

Nauck M, Warnick GR, Rifai N. Methods for Measurement of LDL-Cholesterol: A Critical Assessment of Direct Measurement by Homogeneous Assays versus Calculation. Clin Chem. 2002;48:236–54.

Thông tin
Thông tin xuất bản

BMC Neurology

Tập 16

1-13

Thông tin tác giả